Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Terminated 3Withdrawn 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 9Other solid neoplasm 8Breast 6Sarcoma 5Dermatologic 4Plasma cell 2Other hematologic neoplasm 2Myeloid 2Genitourinary 2CNS 2Other neoplasm 1Lymphoid 1Head & Neck 1Classical hematology 1

Conditions

Sarcoma 3Neoplasm Metastasis 3Melanoma 3Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Lung Neoplasms 1Keratosis, Actinic 1

Interventions

pembrolizumab 100Nivolumab 69Cyclophosphamide 67Ipilimumab 66fludarabine 34aldesleukin 29fludarabine phosphate 28Vemurafenib 28Interleukin-2 26trametinib 20Biopsy 20dabrafenib 17Radiotherapy 16Temozolomide 15Cisplatin 15Magnetic Resonance Spectroscopy 14Gemcitabine 14Filgrastim 14atezolizumab 13Specimen Handling 13Carboplatin 13CTLA-4 Antigen 13spartalizumab 12romidepsin 12Paclitaxel 12Bortezomib 11poly ICLC 10cobimetinib 10Peripheral Blood Stem Cell Transplantation 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Celecoxib × Dermatologic × Clear all
NCT03643744 2024-12-19

Photodynamic Therapy-Induced Immune Modulation: Part III

Wright State University

Phase 1 Terminated
12 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT01313429 2020-03-03

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
19 enrolled
DermatologicSarcomaThoracic

Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Sarcoma

NCT01341496 2018-07-05

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
41 enrolled
DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

NCT02839694 2018-07-05

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Neoplasms, Germ Cell and Embryonal, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡